Related Experiment Video
Updated: Jun 4, 2026

The Perinatal Asphyxiated Lamb Model: A Model for Newborn Resuscitation
Published on: August 15, 2018
Apnea of prematurity: from cause to treatment
Jing Zhao1, Fernando Gonzalez, Dezhi Mu
1Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.
Insights
Apnea of prematurity (AOP) is common in premature infants due to immature respiratory control. Management includes ventilation and methylxanthines, with further research needed for other therapies.
Area of Science:
- Neonatology
- Respiratory Physiology
- Developmental Pediatrics
Background:
- Apnea of prematurity (AOP) affects premature infants due to immature respiratory control.
- Neonatal diseases can worsen AOP by altering responses to hypoxia, hypercapnia, and sleep states.
- The roles of gastroesophageal reflux and anemia in AOP are debated.
Purpose of the Study:
- To discuss the physiology and pathophysiology of AOP.
- To review current and potential therapies for AOP.
- To explore the long-term neurodevelopmental effects of AOP and its treatments.
Main Methods:
- Review of existing literature on AOP physiology, pathophysiology, and treatment.
- Discussion of standard clinical management strategies for AOP.
- Exploration of emerging therapies and their proposed mechanisms.
Main Results:
- AOP is linked to immature respiratory control, altered chemosensitivity, and sleep state disturbances.
- Standard treatments include prone positioning, positive pressure ventilation, and methylxanthines.
- Kangaroo care, transfusions, and CO2 inhalation require further investigation.
Conclusions:
- Understanding AOP pathophysiology is crucial for effective management.
- Current therapies address central and obstructive apnea, but optimal approaches vary.
- Long-term neurodevelopmental outcomes necessitate continued research and monitoring.
Abstract:
Apnea of prematurity (AOP) is a common problem affecting premature infants, likely secondary to a "physiologic" immaturity of respiratory control that may be exacerbated by neonatal disease. These include altered ventilatory responses to hypoxia, hypercapnia, and altered sleep states, while the roles of gastroesophageal reflux and anemia remain controversial. Standard clinical management of the obstructive subtype of AOP includes prone positioning and continuous positive or nasal intermittent positive pressure ventilation to prevent pharyngeal collapse and alveolar atelectasis, while methylxanthine therapy is a mainstay of treatment of central apnea by stimulating the central nervous system and respiratory muscle function. Other therapies, including kangaroo care, red blood cell transfusions, and CO(2) inhalation, require further study. The physiology and pathophysiology behind AOP are discussed, including the laryngeal chemoreflex and sensitivity to inhibitory neurotransmitters, as are the mechanisms by which different therapies may work and the potential long-term neurodevelopmental consequences of AOP and its treatment.
Related Concept Videos
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pulmonary Cycle: Exhalation
Sleep Apnea
The condition is more prevalent among...
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Breathing
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...